{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:38:48Z","timestamp":1791308328262,"version":"4.3.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201810-2017419"],"award-info":[{"award-number":["201810-2017419"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["201810-2017419"],"award-info":[{"award-number":["201810-2017419"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Instituto Carlos III"},{"name":"Instituto Carlos III"},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Robert Koch Institute, German Federal Ministry of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The clinical diagnosis of vascular dementia (VaD) is based on imaging criteria, and specific biochemical markers are not available. Here, we investigated the potential of cerebrospinal fluid (CSF) lipocalin 2 (LCN2), a secreted glycoprotein that has been suggested as mediating neuronal damage in vascular brain injuries. The study included four independent cohorts with a total <jats:italic>n<\/jats:italic>\u2009=\u2009472 samples. LCN2 was significantly elevated in VaD compared to controls, Alzheimer\u2019s disease (AD), other neurodegenerative dementias, and cognitively unimpaired patients with cerebrovascular disease. LCN2 discriminated VaD from AD without coexisting VaD with high accuracy. The main findings were consistent over all cohorts. Neuropathology disclosed a high percentage of macrophages linked to subacute infarcts, reactive astrocytes, and damaged blood vessels in multi-infarct dementia when compared to AD. We conclude that CSF LCN2 is a promising candidate biochemical marker in the differential diagnosis of VaD and neurodegenerative dementias.<\/jats:p>","DOI":"10.1038\/s41467-020-14373-2","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T11:02:57Z","timestamp":1580382177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9756-7497","authenticated-orcid":false,"given":"Franc","family":"Llorens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Villar-Piqu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0262-1498","authenticated-orcid":false,"given":"Daniela","family":"Diaz-Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0194-8402","authenticated-orcid":false,"given":"Katarina","family":"N\u00e4gga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-7286","authenticated-orcid":false,"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Varges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Goebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Dumurgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Baldeiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-8754","authenticated-orcid":false,"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"14373_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jns.2010.08.039","volume":"299","author":"I Ferrer","year":"2010","unstructured":"Ferrer, I. Cognitive impairment of vascular origin: Neuropathology of cognitive impairment of vascular origin. J. Neurol. Sci. 299, 139\u2013149 (2010).","journal-title":"J. Neurol. Sci."},{"key":"14373_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Rom\u00e1n","year":"1993","unstructured":"Rom\u00e1n, G. C. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250\u2013260 (1993).","journal-title":"Neurology"},{"key":"14373_CR3","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1161\/01.STR.31.12.2952","volume":"31","author":"T Pohjasvaara","year":"2000","unstructured":"Pohjasvaara, T., Mantyla, R., Ylikoski, R., Kaste, M. & Erkinjuntti, T. Comparison of Different Clinical Criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the Diagnosis of Vascular Dementia. Stroke 31, 2952\u20132957 (2000).","journal-title":"Stroke"},{"key":"14373_CR4","doi-asserted-by":"crossref","unstructured":"Perneczky, R. et al. Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group. BMC Med. 14, 162 (2016).","DOI":"10.1186\/s12916-016-0719-y"},{"key":"14373_CR5","doi-asserted-by":"crossref","unstructured":"Jellinger, K. A. Pathology and pathogenesis of vascular cognitive impairment-a critical update. Front. Aging Neurosci. 5, 17 (2013).","DOI":"10.3389\/fnagi.2013.00017"},{"key":"14373_CR6","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/brain\/aww214","volume":"139","author":"OA Skrobot","year":"2016","unstructured":"Skrobot, O. A. et al. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain 139, 2957\u20132969 (2016).","journal-title":"Brain"},{"key":"14373_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14373_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","volume":"14","author":"OA Skrobot","year":"2018","unstructured":"Skrobot, O. A. et al. Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimer\u2019s Dement 14, 280\u2013292 (2018).","journal-title":"Alzheimer\u2019s Dement"},{"key":"14373_CR9","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"P Gorelick","year":"2011","unstructured":"Gorelick, P. et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 42, 2672\u20132713 (2011).","journal-title":"Stroke"},{"key":"14373_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/WAD.0000000000000034","volume":"28","author":"P Sachdev","year":"2014","unstructured":"Sachdev, P. et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis. Assoc. Disord. 28, 206\u2013218 (2014).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"14373_CR11","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/brain\/awh553","volume":"128","author":"ND Prins","year":"2005","unstructured":"Prins, N. D. et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 128, 2034\u20132041 (2005).","journal-title":"Brain"},{"key":"14373_CR12","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1212\/WNL.0b013e3181a2e864","volume":"72","author":"K Kantarci","year":"2009","unstructured":"Kantarci, K. et al. Risk of dementia in MCI: Combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 72, 1519\u20131525 (2009).","journal-title":"Neurology"},{"key":"14373_CR13","first-page":"107","volume":"5","author":"J Alber","year":"2019","unstructured":"Alber, J. et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities. Alzheimer\u2019s Dement. Transl. Res. Clin. Inter. 5, 107\u2013117 (2019).","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Inter."},{"key":"14373_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000285521","volume":"7","author":"M Cavalieri","year":"2010","unstructured":"Cavalieri, M. et al. Vascular dementia and Alzheimer\u2019s disease\u2014Are we in a dead-end road?. Neurodegener. Dis. 7, 122\u2013126 (2010).","journal-title":"Neurodegener. Dis."},{"key":"14373_CR15","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: evidence from the dominantly inherited Alzheimer network. Ann. Neurol. 79, 929\u2013939 (2016).","journal-title":"Ann. Neurol."},{"key":"14373_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-017-1738-2","volume":"134","author":"KE McAleese","year":"2017","unstructured":"McAleese, K. E. et al. Parietal white matter lesions in Alzheimer\u2019s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol. 134, 459\u2013473 (2017).","journal-title":"Acta Neuropathol."},{"key":"14373_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2017.00289","volume":"9","author":"F Llorens","year":"2017","unstructured":"Llorens, F. et al. Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease show different but partially overlapping profile compared to vascular dementia. Front. Aging Neurosci. 9, 1\u20139 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"14373_CR18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.jalz.2017.01.026","volume":"13","author":"A Roseborough","year":"2017","unstructured":"Roseborough, A., Ramirez, J., Black, S. E. & Edwards, J. D. Associations between amyloid \u03b2 and white matter hyperintensities: a systematic review. Alzheimer\u2019s Dement. 13, 1154\u20131167 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14373_CR19","doi-asserted-by":"crossref","unstructured":"Wallin, A. et al. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease\u2014A consensus report. BMC Neurol. 17, 102 (2017).","DOI":"10.1186\/s12883-017-0877-3"},{"key":"14373_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jalz.2016.10.007","volume":"13","author":"OA Skrobot","year":"2017","unstructured":"Skrobot, O. A. et al. The vascular impairment of cognition classification consensus study. Alzheimer\u2019s Dement 13, 624\u2013633 (2017).","journal-title":"Alzheimer\u2019s Dement"},{"key":"14373_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-nutr-071816-064559","volume":"37","author":"X Xiao","year":"2017","unstructured":"Xiao, X., Yeoh, B. S. & Vijay-Kumar, M. Lipocalin 2: an emerging player in iron homeostasis and inflammation. Annu. Rev. Nutr. 37, 103\u2013130 (2017).","journal-title":"Annu. Rev. Nutr."},{"key":"14373_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7762\/cnr.2018.7.1.1","volume":"7","author":"J Song","year":"2018","unstructured":"Song, J. & Kim, O. Y. Perspectives in Lipocalin-2: emerging biomarker for medical diagnosis and prognosis for Alzheimer\u2019s disease. Clin. Nutr. Res. 7, 1 (2018).","journal-title":"Clin. Nutr. Res."},{"key":"14373_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jns.2011.03.023","volume":"305","author":"J Choi","year":"2011","unstructured":"Choi, J., Lee, H. W. & Suk, K. Increased plasma levels of lipocalin 2 in mild cognitive impairment. J. Neurol. Sci. 305, 28\u201333 (2011).","journal-title":"J. Neurol. Sci."},{"key":"14373_CR24","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1212\/NXI.0000000000000191","volume":"3","author":"F Al Nimer","year":"2016","unstructured":"Al Nimer, F. et al. Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination. Neurol. \u2014Neuroimmunol. Neuroinflammation 3, e191 (2016).","journal-title":"Neurol. \u2014Neuroimmunol. Neuroinflammation"},{"key":"14373_CR25","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","volume":"28","author":"AR Moschen","year":"2017","unstructured":"Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V. & Tilg, H. Lipocalin-2: a master mediator of intestinal and metabolic inflammation. Trends Endocrinol. Metab. 28, 388\u2013397 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"14373_CR26","doi-asserted-by":"crossref","unstructured":"Gan, J. & Zhou, X. Comparison of urine neutrophil gelatinase-associated lipocalin and interleukin-18 in prediction of acute kidney injury in adults. Medicine (United States) 97 (2018).","DOI":"10.1097\/MD.0000000000012570"},{"key":"14373_CR27","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.2174\/0929867323666160115130241","volume":"23","author":"D Krstic","year":"2016","unstructured":"Krstic, D. et al. Biochemical markers of renal function. Curr. Med. Chem. 23, 2018\u20132040 (2016).","journal-title":"Curr. Med. Chem."},{"key":"14373_CR28","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/glia.23174","volume":"65","author":"JH Kim","year":"2017","unstructured":"Kim, J. H. et al. Astrocyte-derived lipocalin-2 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia. Glia 65, 1471\u20131490 (2017).","journal-title":"Glia"},{"key":"14373_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X18762655","author":"E Barry Erhardt","year":"2018","unstructured":"Barry Erhardt, E. et al. Biomarkers identify the Binswanger type of vascular cognitive impairment. J. Cereb. Blood Flow. Metab. https:\/\/doi.org\/10.1177\/0271678X18762655 (2018).","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"14373_CR30","doi-asserted-by":"crossref","unstructured":"Hermann, P., Romero, C., Schmidt, C., Reis, C. & Zerr, I. CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease. PLoS ONE 9, e105000 (2014).","DOI":"10.1371\/journal.pone.0105000"},{"key":"14373_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.028","volume":"59","author":"T Skillb\u00e4ck","year":"2017","unstructured":"Skillb\u00e4ck, T. et al. CSF\/serum albumin ratio in dementias: a cross-sectional study on 1861 patients. Neurobiol. Aging 59, 1\u20139 (2017).","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"14373_CR32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jalz.2017.12.008","volume":"14","author":"Inga Zerr","year":"2018","unstructured":"Zerr, I. et al. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases. Alzheimer\u2019s Dement. 9, 751\u2013763 (2018).","journal-title":"Alzheimer's & Dementia"},{"key":"14373_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JAD-2011-110566","volume":"27","author":"M Bjerke","year":"2011","unstructured":"Bjerke, M. et al. Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 27, 665\u2013676 (2011).","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"6","key":"14373_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jalz.2016.10.007","volume":"13","author":"Olivia A. Skrobot","year":"2017","unstructured":"Skrobot, O. A. et al. The Vascular Impairment of Cognition Classification Consensus Study. Alzheimer\u2019s Dement. 1\u201310, https:\/\/doi.org\/10.1016\/j.jalz.2016.10.007 (2016).","journal-title":"Alzheimer's & Dementia"},{"key":"14373_CR35","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1136\/jnnp-2014-309421","volume":"86","author":"GA Rosenberg","year":"2015","unstructured":"Rosenberg, G. A. et al. Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials. J. Neurol. Neurosurg. Psychiatry 86, 1324\u20131330 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"14373_CR36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/jnc.14218","volume":"144","author":"GA Rosenberg","year":"2018","unstructured":"Rosenberg, G. A. Binswanger\u2019s disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia. J. Neurochemistry 144, 634\u2013643 (2018).","journal-title":"J. Neurochemistry"},{"key":"14373_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neubiorev.2014.12.006","volume":"49","author":"MK Jha","year":"2015","unstructured":"Jha, M. K. et al. Diverse functional roles of lipocalin-2 in the central nervous system. Neurosci. Biobehav. Rev. 49, 135\u2013156 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"14373_CR38","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1111\/jcmm.12538","volume":"19","author":"G Wang","year":"2015","unstructured":"Wang, G. et al. Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice. J. Cell. Mol. Med. 19, 1637\u20131645 (2015).","journal-title":"J. Cell. Mol. Med."},{"key":"14373_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","volume":"30","author":"AJ Farrall","year":"2009","unstructured":"Farrall, A. J. & Wardlaw, J. M. Blood-brain barrier: ageing and microvascular disease\u2014systematic review and meta-analysis. Neurobiol. Aging 30, 337\u2013352 (2009).","journal-title":"Neurobiol. Aging"},{"key":"14373_CR40","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/glia.22342","volume":"60","author":"JL Berard","year":"2012","unstructured":"Berard, J. L. et al. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia 60, 1145\u20131159 (2012).","journal-title":"Glia"},{"key":"14373_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","volume":"96","author":"EV Mike","year":"2019","unstructured":"Mike, E. V. et al. Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus. J. Autoimmun. 96, 59\u201373 (2019).","journal-title":"J. Autoimmun."},{"key":"14373_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1615\/CritRevImmunol.2015012127","volume":"35","author":"S Lee","year":"2015","unstructured":"Lee, S., Jha, M. K. & Suk, K. Lipocalin-2 in the inflammatory activation of brain astrocytes. Crit. Rev. Immunol. 35, 77\u201384 (2015).","journal-title":"Crit. Rev. Immunol."},{"key":"14373_CR43","doi-asserted-by":"crossref","unstructured":"Taklimie, F. R. et al. Hypoxia induces astrocyte-derived lipocalin-2 in ischemic stroke. Int. J. Mol. Sci. 20, 1271 (2019).","DOI":"10.3390\/ijms20061271"},{"key":"14373_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3233\/JAD-2008-14110","volume":"14","author":"Ka Jellinger","year":"2008","unstructured":"Jellinger, Ka The pathology of \u2018vascular dementia\u2019: a critical update. J. Alzheimers Dis. 14, 107\u2013123 (2008).","journal-title":"J. Alzheimers Dis."},{"key":"14373_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"14373_CR46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois, B. et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6, 734\u2013746 (2007).","journal-title":"Lancet Neurol."},{"key":"14373_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois, B. et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria. Lancet Neurol. 13, 614\u2013629 (2014).","journal-title":"Lancet Neurol."},{"key":"14373_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"14373_CR49","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre, M. et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov. Disord. 22, 1689\u20131707 (2007).","journal-title":"Mov. Disord."},{"key":"14373_CR50","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky, K. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134, 2456\u20132477 (2011).","journal-title":"Brain"},{"key":"14373_CR51","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr, I. et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132, 2659\u20132668 (2009).","journal-title":"Brain"},{"key":"14373_CR52","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","volume":"32","author":"LO Wahlund","year":"2001","unstructured":"Wahlund, L. O. et al. A new rating scale for age-related white matter changes. Stroke 32, 1318\u20131322 (2001).","journal-title":"Stroke"},{"key":"14373_CR53","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/bimj.200810425","volume":"50","author":"T Hothorn","year":"2008","unstructured":"Hothorn, T., Bretz, F. & Westfall, P. Simultaneous inference in general parametric models. Biometrical J. 50, 346\u2013363 (2008).","journal-title":"Biometrical J."},{"key":"14373_CR54","doi-asserted-by":"crossref","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","DOI":"10.1186\/1471-2105-12-77"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14373-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14373-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14373-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T17:44:09Z","timestamp":1670262249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14373-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14373"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-14373-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]},"assertion":[{"value":"14 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.B. has served as a consultant or on the advisory boards for Alzheon, BioArctic, Biogen, Eli Lilly, Fujirebio Europe, IBL International, Merck, Novartis, Pfizer, and Roche Diagnostics, all un-related to the data presented in the present paper. O.H. has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy\/speaker fees (paid to the institution) from Biogen, Roche, and Fujirebio. H.Z. has served on scientific advisory boards for Eli Lilly, Roche Diagnostics, CogRx, Samumed, and Wave, has received travel support from Teva and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. C.P. is member of the International Advisory Boards of Lilly, is consultant of Fujiribio, ALZOHIS, NEUROIMMUNE, and GILEAD and is involved as investigator in several clinical trials for Roche, Esai, Lilly, Biogen, Astra-Zeneca, Lundbeck, and Neuroimmune. J.D. is an investigator in several passive anti-amyloid immunotherapies and other clinical trials for Roche, Eisai, Lilly, Biogen, Astra-Zeneca, Lundbeck. The remaining authors report no biomedical financial interests or potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"619"}}